Lenvatinib Plus Gefitinib Promising in Liver Cancer Lenvatinib Plus Gefitinib Promising in Liver Cancer

In patients with advanced liver cancer who were unresponsive to lenvatinib, adding gefitinib led to a clinically meaningful response in a proof-of-concept study.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news